B. Riley Has Optimistic Outlook of Altimmune FY2025 Earnings
Altimmune, Inc. (NASDAQ:ALT – Free Report) – Stock analysts at B. Riley increased their FY2025 earnings estimates for Altimmune in a research note issued on Friday, February 28th. B. Riley analyst M. Mamtani now forecasts that the company will earn $0.86 per share for the year, up from their previous estimate of $0.73. The consensus […]
Altimmune, Inc. (NASDAQ:ALT – Free Report) – Stock analysts at B. Riley increased their FY2025 earnings estimates for Altimmune in a research note issued on Friday, February 28th. B. Riley analyst M. Mamtani now forecasts that the company will earn $0.86 per share for the year, up from their previous estimate of $0.73. The consensus […]
